Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Arkadir

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 20, 2020
A synergistic effect of Ambroxol and Beta-Glucosylceramide in alleviating immune-mediated hepatitis: A novel immunomodulatory non-immunosuppressive formulation for treatment of immune-mediated disordersTawfik Khoury, Yuval Ishay, Devorah Rotnemer-Golinkin, et al.
Neurological Research|May 4, 2011
Preliminary experience with the use of self-expanding stent as a thrombectomy device in ischemic strokeJosé E Cohen, John M Gomori, Ronen R Leker, et al.
Movement Disorders Clinical Practice|January 31, 2024
Novel RAB39B Mutation Causes Parkinsonism in Males with Developmental DisorderRoy Dayan, Shiri Shkedi Rafid, Halen Baker Erdman, et al.
Neurology|July 17, 2013
Lipoid proteinosis with bilateral amygdalae calcifications, headache, and cognitive impairmentsDavid Arkadir, Israela Lerer, Laurent Klapholz, et al.
Blood Cells, Molecules & Diseases|November 20, 2016
Trio approach reveals higher risk of PD in carriers of severe vs. mild GBA mutationsDavid Arkadir, Tama Dinur, Stephen Mullin, et al.
IBRO Neuroscience Reports|March 19, 2026
A feasibility open-label clinical trial utilizing second-generation artificial intelligence based on the constrained-disorder principle in patients with Parkinson's diseaseHillel Lehmann, Henny Azmanov, Yoav Hershkovitz, et al.
Harefuah|July 25, 2019
[DEEP BRAIN STIMULATION FOR OBSESSIVE COMPULSIVE DISORDER: CASE REPORT OF THE FIRST OCD PATIENT IN ISRAEL]Renana Eitan, David Arkadir, Eduard Linetsky, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 3, 2007
Shaping of motor responses by incentive values through the basal gangliaBenjamin Pasquereau, Agnes Nadjar, David Arkadir, et al.
Frontiers in Neurology|November 28, 2022
The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development programPeter A LeWitt, Fabrizio Stocchi, David Arkadir, et al.
Movement Disorders Clinical Practice|July 7, 2020
Benign SLC39A14 Course of Dystonia-Parkinsonism Secondary to Inherited Manganese AccumulationMontaser Namnah, Max Bauer, Hagar Mor-Shaked, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 20, 2020
A synergistic effect of Ambroxol and Beta-Glucosylceramide in alleviating immune-mediated hepatitis: A novel immunomodulatory non-immunosuppressive formulation for treatment of immune-mediated disordersTawfik Khoury, Yuval Ishay, Devorah Rotnemer-Golinkin, et al.
Neurological Research|May 4, 2011
Preliminary experience with the use of self-expanding stent as a thrombectomy device in ischemic strokeJosé E Cohen, John M Gomori, Ronen R Leker, et al.
Movement Disorders Clinical Practice|January 31, 2024
Novel RAB39B Mutation Causes Parkinsonism in Males with Developmental DisorderRoy Dayan, Shiri Shkedi Rafid, Halen Baker Erdman, et al.
Neurology|July 17, 2013
Lipoid proteinosis with bilateral amygdalae calcifications, headache, and cognitive impairmentsDavid Arkadir, Israela Lerer, Laurent Klapholz, et al.
Blood Cells, Molecules & Diseases|November 20, 2016
Trio approach reveals higher risk of PD in carriers of severe vs. mild GBA mutationsDavid Arkadir, Tama Dinur, Stephen Mullin, et al.
IBRO Neuroscience Reports|March 19, 2026
A feasibility open-label clinical trial utilizing second-generation artificial intelligence based on the constrained-disorder principle in patients with Parkinson's diseaseHillel Lehmann, Henny Azmanov, Yoav Hershkovitz, et al.
Harefuah|July 25, 2019
[DEEP BRAIN STIMULATION FOR OBSESSIVE COMPULSIVE DISORDER: CASE REPORT OF THE FIRST OCD PATIENT IN ISRAEL]Renana Eitan, David Arkadir, Eduard Linetsky, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 3, 2007
Shaping of motor responses by incentive values through the basal gangliaBenjamin Pasquereau, Agnes Nadjar, David Arkadir, et al.
Frontiers in Neurology|November 28, 2022
The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development programPeter A LeWitt, Fabrizio Stocchi, David Arkadir, et al.
Movement Disorders Clinical Practice|July 7, 2020
Benign SLC39A14 Course of Dystonia-Parkinsonism Secondary to Inherited Manganese AccumulationMontaser Namnah, Max Bauer, Hagar Mor-Shaked, et al.
Pageof 10